Parkway Life REIT (PLife REIT) is thriving and winning through collaborations with its sponsor, says UOB Kay Hian Research analyst Jonathan Koh. 

“We expect the extension of master leases for three hospitals in Singapore to come with an increase in rents of 12% for the first year of the new 15-year master leases,” notes Koh in a Feb 9 note. 

Koh is maintaining his “buy” call on PLife REIT with a raised target price of $4.38 from $3.80.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook